PCP
ZBH icon

Perbak Capital Partners’s Zimmer Biomet ZBH Stock Holding History

Perbak Capital Partners’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,115
Closed -$460K – 394
2025
Q4 		$460K Sell
5,115
-9,042
-64% -$857K 0.14% 47
2025
Q3 		$1.39M Buy
14,157
+10,439
+281% +$1.03M 0.25% 43
2025
Q2 		$339K Buy
+3,718
New +$360K 0.08% 231
2025
Q1 		– Sell
-5,280
Closed -$558K – 227
2024
Q4 		$558K Buy
+5,280
New +$567K 0.3% 55

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Perbak Capital Partners's ZBH Position: Q1 2026 in Review

Perbak Capital Partners sold out of Zimmer Biomet (ZBH) in Q1 2026, closing a stake of 5,115 shares — an estimated $460K sold.

Perbak Capital Partners first reported a position in ZBH in Q4 2024 and held it in 4 quarters. The position peaked at $1.39M in Q3 2025. 916 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Perbak Capital Partners reported no remaining Zimmer Biomet position as of Q1 2026 after selling out during the quarter.
  • Perbak Capital Partners sold 5,115 Zimmer Biomet shares in Q1 2026, an estimated $460K.
  • Perbak Capital Partners first reported a position in Zimmer Biomet in Q4 2024 and held it in 4 quarters.
  • Perbak Capital Partners's Zimmer Biomet position peaked at $1.39M in Q3 2025.
  • 916 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Perbak Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.